In order to reduce postoperative opioid requirement, extrapleural local anaesthetic infusion dosing recommendations and guidelines for extrapleural catheter insertion were developed in our institution for 'extubatable' neonates requiring short-gap neonatal tracheo-oesophageal fistula/oesophageal atresia repair (via thoracotomy) and audited prospectively. Data audited included patient characteristics, analgesia details and ventilation duration. We divided patients into two groups: group 1 -term patients (≥36 weeks gestational age) with birth-weights ≥2.5 kg; group 2 -pre-term patients (<36 weeks gestational age), with birth weights <2.5 kg and those with co-morbidities. There were 26 neonates in group 1 and 11 in group 2. All received extrapleural infusions of bupivacaine or levobupivacaine: the majority (90%) ≤300 μg.kg -1 .hour -1 (median duration 43 hours, range 1.5 to 72 hours); 36% required morphine infusion and 39% were ventilated (median duration 34 hours, range 3 to 140 hours). In group 1, 24% required morphine infusion compared with 64% in group 2. Most group 1 patients (77%) were extubated immediately postoperatively; 20% had short duration ventilation (median 15 hours, range 11 to 37 hours); one required longer-term ventilation (231 hours). 82% of group 2 were ventilated for a median of 72 hours (range 3 to 140 hours). Review of patients' co-morbidities facilitated guideline revision. These now specify use in neonates requiring short-gap tracheo-oesophageal fistula/oesophageal atresia repair who are term at ≥36 weeks gestational age and ≥2.5 kg birth-weight, anticipated as ready for extubation either immediately or shortly after surgery.
Intravenous (IV) opioid analgesia following tracheo-oesophageal fistula/oesophageal atresia (TOF-OA) repair may cause respiratory depression in neonates extubated immediately or shortly after surgery. Subsequent high-pressure manual bagmask ventilation and emergency reintubation in the neonatal intensive care unit (NICU) may jeopardise the surgical anastomosis. Regional analgesic techniques used for children post-thoracotomy to reduce or avoid postoperative opioids previously described include an extrapleural technique for TOF-OA surgery 1 and extrapleural [2] [3] [4] [5] , interpleural 6-10 and epidural 11 local anaesthetic infusion.
For postoperative TOF-OA patients, our surgical NICU's management has changed from a prolonged nil-oral regimen (perceived to facilitate anastomotic healing) to earlier extubation and introduction of feeding. Some NICUs electively sedate, paralyse and ventilate all post TOF-OA repair patients for one to three days, nursing them with the neck flexed: some choose this only for patients having moderate or long-gap repairs. Our surgeons wished to pursue early postoperative extubation and regional analgesia following thoracotomy for short-gap TOF-OA repair in appropriate robust neonates where the anastomosis is not under tension. They suggested using an extrapleural analgesic technique in neonates with TOF-OA who did not require ventilation for other reasons to avoid morphine infusion and its potential contribution to delay in extubation, feeding and discharge. An interdisciplinary meeting identified neonates suitable for extubation at the end of their surgery and the pain service developed guidelines for extrapleural catheter insertion and local anaesthetic infusion. An audit was performed to assess the adequacy and confirm appropriate selection criteria for the analgesic intervention.
METHODS
This prospective audit was performed at the Royal Children's Hospital, a tertiary referral hospital for neonatal surgery where approximately 10 to 15 TOF-OA neonates are managed per year. As per institutional practice at the time, approval for the audit was granted by the Divisional Director without requirement for parental consent. Subsequently, the audit and its planned publication were endorsed by the Royal Children's Hospital Human Research Ethics Committee (endorsement letter dated 22 September 2011). Guidelines were formed for neonates anticipated to tolerate early extubation (immediate or following 'convenient' overnight ventilation) to have an extrapleural catheter placed. The treating neonatologist, surgeon and anaesthetist discussed each individual patient's 'robustness' preoperatively, and the catheter was placed if the patient's intraoperative course was stable. Initially, extrapleural catheters were inserted in term neonates of robust weight who had no other comorbidity (such as major lung, abdominal or cardiac abnormalities). Subsequently, the technique was utilised in neonates that were preterm, lower in birthweight or who had other co-morbidities, anticipating that early postoperative extubation may be facilitated.
Our surgical approach to short-gap TOF-OA repair involves posterolateral thoracotomy (fourth intercostal space) with extrapleural dissection (without pre-procedure bronchoscopy). The azygos vein is divided for access to perform fistula division and primary oesophageal segment anastomosis. Following the repair, an 18 G Tuohy needle is inserted through the fifth intercostal space between the mid and posterior axillary lines. An end-hole 20 G Portex ® catheter (SIMS Portex Limited, Kent, UK) is passed through this, to lie within the dissected extrapleural space. The distal portion of the catheter lies vertical and is loosely sutured in the paravertebral gutter with the tip pointing rostrally (adjacent to the thoracotomy level) ( Figure 1 ). After flushing confirms catheter patency, the retracted parietal pleura is released and the lung re-inflated. Exteriorly, the catheter is sutured to the skin and a dressing applied. The anaesthetist involved would notify the pain service that an extrapleural catheter was inserted.
The initial infusion guidelines were developed in September 2002. These recommended an initial bolus of 250 to 500 μg.kg -1 , then infusion 125 μg.kg -1 . hour -1 of racemic bupivacaine 0.0625%. The low concentration was selected to allow higher volumes to be infused.
The highest pain score during four postoperative time epochs was recorded: 0 to 6 hours, 6 to 12 hours, 12 to 24 hours and 24 to 36 hours. The patients' pain was scored using the Patient Assessment Tool (PAT). This is a validated neonatal pain assessment tool based on the infant's behavioural and physiological variables and nurse observational assessment with 10 variables assigned a 0 to 2 value with a total score range of 0 to 20 12 . This tool has three categories: 0 to 5 indicating the patient is comfortable, 6 to 9 indicating that comfort measures should be insituted, and scores >10 indicating analgesic adjustment is required 12 .
Patients were reviewed twice daily and prn by the pain service. Adjustments to the local anaesthetic infusion were pre-specified. For PAT scores >6, a standing order for a 125 μg.kg -1 bupivacaine extrapleural bolus was available, maximum three bolus doses in any six-hour period. The infusion rate could be increased after discussion with or review by the pain service to 187.5 then 250 μg.kg -1 .hour -1 (and similarly the bolus size) if PAT scores were >6 or >2 boluses were required. During the audit, levobupivacaine replaced racemic bupivacaine premade infusion bags; the same doses and concentrations of levobupivacaine were used. Paracetamol was prescribed prn: 20 mg.kg -1 six hourly rectally and from March 2005 as 7.5 mg.kg -1 IV six hourly. If despite these measures the PAT score was >6, codeine 0.5 to 1 mg.kg -1 rectally four hourly, tramadol 1 to 2 mg.kg -1 IV six hourly or morphine infusion 5 to 40 μg.kg -1 .hour -1 were commenced at neonatal staff discretion.
Data collection and statistical analysis
Neonatal nursing and pain service staff completed the patient data sheets. Data collected included patient characteristics, co-morbidities, surgery type/s and duration, anaesthetic details including intraoperative opioid, extrapleural infusion details, analgesics (adjuvant, rescue and step-down), postoperative ventilation duration, complications, time to full enteral feeds and discharge.
Data were entered using Microsoft Excel (2000, Microsoft Corp., Redmond, WA, USA) and analysed using Stata 9 (2005, Stata Statistical Software, StataCorp, TX, USA). Normally distributed data are presented as mean values±SD, non-normal as median and range.
The data are presented for two groups: group 1, term patients ( ≥36 weeks gestational age) with birth weights ≥2.5 kg; and group 2, pre-term patients, (<36 weeks gestational age), patients with birth weights <2.5 kg, and those with co-morbidities. The co-morbidities present were divided into categories: cardiac, respiratory, abdominal, systemic and additional surgery at the time of TOF-OA repair or later. The authors incorporated the co-morbidities seen in redrafting the final guidelines. Patients who required rescue with morphine or systemic analgesic infusion had their data individually reviewed. Statistical comparisons were not performed as patient numbers were small and confounding factors were numerous.
RESULTS
Five surgeons performed short-gap TOF-OA repair on 56 patients over the four-and-a-half year audit period (September 2002 to February 2007). Fifteen patients did not fulfil extrapleural guidelines with low birthweight and prematurity (9 of 15) or had co-morbidities of cardiac disease, vascular anomaly, VACTERAL (Vertebral, Anal, Cardiac, Tracheo-Esophageal fistula/Esophageal atresia, Renal and Limb anomalies) association (VACTERL, US spelling) or intestinal atresia (13 of 15). They received intercostal nerve blocks and morphine infusions. Two patients who fulfilled extrapleural guidelines received a caudally-threaded thoracic epidural (per anaesthetist choice). Thirty-nine patients received an extrapleural catheter. Two term neonates had extrapleural and morphine infusions commenced concurrently, but upon review of their co-morbidities (duodenal atresia and cardiac disease/ failure with thrombocytopenia) the next morning, the extrapleural infusion was ceased as extubation was not imminent. Thus data are presented for 37 neonates: 26 in group 1 and 11 in group 2.
Neonates received a balanced anaesthetic comprising air/O 2 /volatile agent, muscle relaxant and 95% received intraoperative opioid. Anaesthetists varied in their intraoperative opioid administration practices. They more frequently gave group 1 patients fentanyl over morphine (61 vs 32%) and lower doses than group 2 patients (median 2 vs 7 μg.kg -1 and 64 vs 100 μg.kg -1 respectively). Table 1 lists patient characteristics, co-morbidities, surgical duration, morphine requirements and time of extubation. Three neonates required additional surgery at the time of TOF-OA repair: one term neonate required a minor anoplasty and two preterm patients required laparotomy (a Ladd's procedure and colostomy for imperforate anus respectively). Most group 1 patients did not receive postoperative morphine infusion. Most were extubated immediately: the clinicians opted to 'conveniently' ventilate six patients. Three were ventilated overnight and two for a day and a night. The sixth patient's data are excluded from the ventilation duration section as this patient developed anastomotic leak on post-operative day 1 and was ventilated for 231 hours.
Anaesthetists complied variably with the recommended loading dose: 15 (41%) patients received a median dose of 491 μg.kg -1 (range 227 to 2200); two patients received intercostal nerve blocks and the remaining 20 received no load. The median maximum infusion rates were similar for bupivacaine (n=12, 27%: 241 [range 125 to 269] μg.kg -1 .hour -1 ) and levobupivacaine (n=25, 73%: 227 [range 122 to 341] μg.kg -1 .hour -1 ). The median duration of extrapleural infusion was 43 hours (range 1.5 to 72); with a maximum infusion rate ≤250 to 300 μg.kg -1 .hour -1 for the majority (75 to 90%). Twenty (77%) group 1 neonates required bolusing a median of three times (range 1 to 10), 10 of whom had the extrapleural infusion rate increased. Five (45%) group 2 neonates received boluses a median of three times (range 1 to 4), three of whom had the infusion rate increased. Regarding adjunctive analgesics, the majority (89%) of patients received paracetamol as adjuvant and step-down analgesia. Of group 1 patients, two (8%) received no adjuvant therapy (extrapleural infusion rates of 243 and 250 μg.kg -1 .hour -1 ), and nine (35%) required only adjuvant paracetamol (two had infusion rate increases; maximum extrapleural infusion rates ranging from 125 to 250 μg.kg -1 .hour -1 ) and four (16%) received a single daily dose of codeine (two with sucrose, two with chloral hydrate: one of each of these required infusion rate increase; maximum rates were 129 to 243 μg.kg -1 .hour -1 ). Seven further group 1 patients (with maximum infusion rates of 185 to 298 μg.kg -1 .hour -1 ) received adjuvant tramadol 2 mg.kg -1 IV: one dose (three patients), two doses (two patients: one patient co-received sucrose and infusion rate increase), three doses (one patient whose infusion rate was increased) and four doses (this patient also received seven codeine doses and is described in Table 2 ). Notably for seven group 1 patients after removal of functioning catheters (at 35 to 41 hours), step-down medication beyond paracetamol was administered: regular high-dose chloral hydrate (two), regular codeine (one), tramadol (two), tramadol and chloral (one) and tramadol, chloral and a 50 μg.kg -1 IV morphine bolus (one).
The neonatal nurses documented the PAT scores well initially: 97% in the first epoch decreasing to were between six and nine. Scores were similar for 'preterm/low birthweight/co-morbidity' patients, independent of morphine use. Table 2 provides details of eight group 1 patients (37 to 40 weeks gestational age; weighing 2.7 to 3.2 kg) who required rescue with morphine (six) or other systemic analgesic infusion (two) with data sheet comments, complications experienced and a concluding comment after two author review. Table 3 lists other postoperative outcomes. More neonates in group 1 developed 'anastomotic leak' and 'wound infections' (one wound erythema only and three wound erythema and slight ooze which was culture negative and which rapidly resolved without systemic sepsis). Exit-site leak was noted in two of the 'wound infection' patients, two patients where the extra-pleural technique was deemed ineffective ( Table 2 ) and in three patients thought to have effective analgesia, totalling eight (22%).
[Note: The surgeons now dress the catheter exitsite separately with a non-occlusive dressing in case moisture retention has been contributing to wound erythema].
DISCUSSION
The largest prospectively audited case series of extrapleural local anaesthetic infusion use following neonatal TOF-OA repair is presented. The audit demonstrates that this technique provides satisfactory analgesia post-thoracotomy for the majority of term neonates of robust weight and without comobidities, extubated immediately or after overnight ventilation. The technique's efficacy is supported in that 59% received either no or minimal adjuvant analgesics (paracetamol and codeine), 75% had low PAT scores (64% when including undocumented scores in the denominator) and morphine infusion was not required in 76%.
This audit's results should be interpreted acknowledging the lack of blinding to the extrapleural intervention. Additionally, there was variation in intraoperative opioid use, extrapleural local anaesthetic loading dose, bolus and continuous infusion rate administration, and the institution of morphine and adjuvant analgesics at NICU staff discretion rather than based on specific criteria. Of the patients who required systemic intervention, morphine and tramadol may have been avoided with extrapleural infusion rate increase in four of the eight patients. In addition to inadequate dosing, further potential explanations for reduced extrapleural infusion efficacy include catheter dislodgement or misplacement, differences in the extent of surgical extrapleural dissection, the degree of extrapleural catheter exit-site leak and additional surgical procedures outside the scope of extrapleural analgesia. For the patients requiring rescue with systemic agents other than morphine, in three patients anastomotic leak later became evident, providing an alternative explanation for the high early pain scores and requirement for multiple analgesics.
The audit design and small patient numbers limit the assessment of impact upon other outcomes. Intraoperative opioid type and dose may have influenced time to extubation. Comparison between the two subgroups was not appropriate as lower gestational age and birthweight may influence surgical technique and ease, and respiratory function. While 'preterm/low birthweight/comorbidity' patients also had low pain scores, assessment of the analgesic efficacy of extrapleural infusion in this group was limited by small sample size, the presence of co-morbidities independently requiring ventilation, additional surgery that the extrapleural infusion would not cover and the concurrent need for morphine infusion to facilitate endotracheal intubation and ventilation over and above analgesic requirement.
While patient selection guidelines were provided, the treating specialists (neonatologist, surgeon and anaesthetist) could choose, after discussion, to offer extrapleural analgesia to any patient they thought appropriate. Insertion therefore occurred in preterm, underweight patients and neonates with co-morbidities not defined in the initial criteria. This led to criteria refinement for birthweight and co-morbidities (Table 4 ). As patient numbers were small, it was not possible to statistically confirm the predictive nature of these factors, which independently and together influence postoperative ventilation. Education and repeated inter-departmental presentation improved adherence to the perioperative guidelines. Extrapleural catheters are classically inserted via a transcutaneous-posterior or intrathoracicanterior approach (by anaesthetists and surgeons respectively) to lie in the extrapleural space with the distal catheter vertical in the paravertebral gutter. Here, the parietal pleura adherence to the ribs is deficient with the infused local anaesthetic contained in a paravertebral extrapleural pocket spreading to dermatomal segments above and below the catheter tip 4 . Vane et al 1 described a 'retro' (i.e. extra) pleural surgical approach, inserting the catheter superiorly to lie perpendicular to the thoracotomy wound in the lateral aspect of the chest wall. As in our series, the local anaesthetic diffuses within the dissected extrapleural space and both can be termed 'non-contained' extrapleural infusions. Factors contributing to impaired efficacy of interpleural catheters over 'contained' extrapleural catheters 2,3 may therefore apply to 'non-contained' extrapleural catheters. These factors include local anaesthetic dilution by blood or inflammatory fluid, positiondependent analgesia (relevant for older children/ adults when nursed upright) 8 , loss of local anaesthetic into chest drains (documented as 10% per hour 13 ) or via the catheter exit-site (leak is not described in previous 'contained' extrapleural infusion reports), and larger potential surface area for diffusion and systemic absorption. Anticipating this, the lowconcentration higher volume local anaesthetic infusion regimen was implemented and was efficacious.
Notably, in Vane et al's study 1 , TOF-OA patients received extrapleural infusion at considerably higher μg.kg -1 .hour -1 dosing (1.5 to 3.2 times higher) for a much longer period (mean 118 hours, range 48 to 240 hours). No toxicity was evident clinically but plasma assays were not performed to support the safety of their regimen. Opioid infusion was not necessary in any of their 10 patients, only three required rate adjustment and one received supplemental rectal paracetamol. The data provided on the number of times residents were called to a patient (mean of 0.7, range 0 to 5 times) for pain, distress or 'fussiness' is difficult to interpret, as the overlap with those who then received analgesic intervention was unspecified. We chose an initial lower local anaesthetic dosing regimen with prescription guidelines permitting up-titration based upon an individual's pain scores. Paracetamol co-administration was encouraged and the majority of patients received it. Interestingly, a large number of our patients required bolusing and rate increase and a proportion (25%) of our maximum infusion rates overlapped with 50% in the series by Vane et al. Our prescription guidelines were subsequently revised after review of our patients' maximum infusion rates at two time points (after patients 14 in 2004 and 31 in 2006).
As nearly one-third of our group 1 patients required more than paracetamol following extrapleural catheter removal before 41 hours, continuing extrapleural infusions following TOF-OA repair to 72 hours, as recommended post-thoracotomy for older children 4 , is now a consideration. However, a valid concern in neonates is bupivacaine toxicity with prolonged infusions. Vane and co-workers' 10 patient series 1 was too small to draw safety conclusions. Cardiovascular and central nervous system local anaesthetic toxicity is described in children and adults with serum bupivacaine concentrations between 2 to 4 μg.ml -1 7,14 . Children were thought more resistant to local anaesthetic toxicity 11 , but this concept is not well studied. Physiological differences may exacerbate local anaesthetic toxicity in the neonate because of low α1-acid glycoprotein concentration, increased volume of distribution, immature hepatic metabolism with reduced clearance 15 , immature blood-brain barrier and higher cardiac index leading to a rapid rise in local anaesthetic concentration and accumulation 16 . Additional considerations are loading dose administration while anaesthetised (which may mask central nervous system toxicity signs), utilising local anaesthetic in a site with good systemic absorption (as evident from interpleural 8 and 'contained' extrapleural reports 3, 5 ) and continuous infusion associated with cumulative serum bupivacaine concentration rise 15 . Several authors report toxic concentrations with extrapleural 3,5 and inter-pleural techniques 8,10 with high loading doses 1250 μg.kg -1 3,5 and infusions of 250 5 , 500 3,10 and 1250 to 2500 8 μg.kg -1 .hour -1 and one child with lung vascular lesions had clinical toxicity 10 . These articles validate more conservative dosing regimens, especially in neonates. Levobupivacaine was used preferentially, once available, as it is considered less cardiotoxic than the racemic form 17 . However, like ropivacaine 18 , its clearance is reduced in neonates 19 and caution should be exercised. Our neonates received variable loading doses with the majority receiving levobupivacaine and infusions <250 to 300 μg.kg -1 . hour -1 . Although these rates are less than the recommended 400 μg.kg -1 .hour -1 for contained 4 extrapleural bupivacaine infusions and generally less than infused in the previous non-contained neonatal TOF-OA series 1 , serum levobupivacaine concentrations have not been measured at these dosing schedules and these measurements are required to affirm the current extrapleural infusion dosing recommendations and safety of infusion into a dissected extrapleural space.
The surgical complications of 'wound infection' (11%) and anastomotic leak (14%) are a concern. An extrapleural catheter may predispose towards wound infection as a foreign body, providing an additional entry portal, and the infusion and exit-site leak may contribute to wound oedema and impair healing. Importantly, patient wound cultures were negative without systemic consequence. The bactericidal property of high concentrations of bupivacaine is reported 20 but is not established for levobupivacaine. Laboratory study of the latter and further data of skin and oesophageal anastomotic integrity in a larger series is required. Anastomotic leak also occurred in two of 17 patients (12%) who did not receive an extrapleural catheter: one premature neonate managed with morphine and one term neonate managed with an epidural (unpublished data). Conversely, extrapleural analgesia could theoretically reduce the incidence of infection through provision of better analgesia, thereby modulating immune or stress responses and also possibly by a local anaesthetic antibacterial effect. No previous reports of these outcomes post TOF-OA repair are available for comparison and our patient series is too small and heterogeneous to draw conclusions.
As a result of this audit, when presented with a neonate requiring TOF-OA repair, our anaesthetists liaise closely with the surgeon and neonatologist, jointly reviewing the patient's condition and comorbidities. A team decision is thus made as to the individual's appropriateness for early extubation, whereby extrapleural analgesia can then be considered. We continue with the extrapleural local anaesthetic infusions in selected neonates, applying the revised criteria (Table 4 ) and recommend a low concentration and dose of levobupivacaine (0.0625%: loading dose of 500 μg.kg -1 and infusion of 250 μg.kg -1 .hour -1 ) for 48 to 60 hours. A pharmacokinetic study is required to confirm safety.
